A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer

Clinical trial NCT06471673 · RECRUITING

Trial details

NCT number: NCT06471673
Sponsor: BriaCell Therapeutics Corporation
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Tumor Cancer of Breast Cancer of the Breast Malignant Tumor of Breast Tumors, Breast

Start date: 2024-05-29
Primary completion: 2025-04-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.